Search results
Moderna (NASDAQ:MRNA) PT Raised to $106.00
ETF DAILY NEWS· 19 hours agoCanaccord Genuity Group currently has a hold rating on the stock. William Blair restated a market perform rating on shares of Moderna in a report on Monday ...
Why Moderna Stock Blasted 13% Higher Today
Motley Fool via Yahoo Finance· 5 days agoNormally, investors wouldn't reward such declines and steep shortfalls. But the market was braced for a notably worse showing. On average, analysts...
Moderna Breaks Out For The First Time In A Year After Covid Shot Wallops Sales Views
Investor's Business Daily· 5 days agoModerna stock broke out for the first time in a year on Thursday after beating Wall Street's...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 5 days agoModerna stock broke out for the first time in over a year on May 2 after the biotech company notched...
Moderna stock surges 15% after it beat earnings expectations despite plummeting COVID vaccine sales
Quartz· 5 days agoModerna stock soared on Thursday after its first-quarter earnings report sailed past Wall Street’s...
Insider Sale Alert: Moderna Inc [MRNA] – Is it Time to sell? – Knox Daily
Knox Daily· 14 hours agoPrice Performance Review of MRNA On Monday, Moderna Inc [NASDAQ:MRNA] saw its stock fall -2.30% to $122.13. Over the last five days, the stock& ...
Check Out What Whales Are Doing With MRNA - Moderna (NASDAQ:MRNA)
Benzinga· 4 hours agoModerna, we move to examine the company in more detail. This includes an assessment of its current market status and performance. Where Is Moderna Standing ...
Moderna Stock Takes Minimal Hit After New COVID Vaccine Topped Projected Estimates
Black Enterprise· 4 days agoModerna announced an increase in stock price after their COVID vaccine exceeded sales estimates for...
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga via Yahoo Finance· 5 days agoThursday, Moderna Inc (NASDAQ:MRNA) reported a first-quarter EPS loss of $(3.07), down from an...
Royal Bank of Canada Increases Moderna (NASDAQ:MRNA) Price Target to $135.00
ETF DAILY NEWS· 3 days agoRoyal Bank of Canada’s target price would indicate a potential upside of 8.00% from the stock’s previous close. Canaccord Genuity Group boosted their price objective on < ...
